- Home
- CFSB vs CUE Comparison
CFSB vs CUE Comparison
Compare CFSB & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- CUE
- Stock Information
- Founded
- CFSB 1889
- CUE 2014
- Country
- CFSB United States
- CUE United States
- Employees
- CFSB N/A
- CUE N/A
- Industry
- CFSB Major Banks
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- CFSB Finance
- CUE Health Care
- Exchange
- CFSB Nasdaq
- CUE Nasdaq
- Market Cap
- CFSB 51.6M
- CUE 59.5M
- IPO Year
- CFSB N/A
- CUE 2018
- Fundamental
- Price
- CFSB $13.90
- CUE $0.83
- Analyst Decision
- CFSB
- CUE Strong Buy
- Analyst Count
- CFSB 0
- CUE 2
- Target Price
- CFSB N/A
- CUE $3.00
- AVG Volume (30 Days)
- CFSB 1.3K
- CUE 150.4K
- Earning Date
- CFSB 08-26-2025
- CUE 08-12-2025
- Dividend Yield
- CFSB N/A
- CUE N/A
- EPS Growth
- CFSB N/A
- CUE N/A
- EPS
- CFSB N/A
- CUE N/A
- Revenue
- CFSB $7,484,000.00
- CUE $8,286,000.00
- Revenue This Year
- CFSB N/A
- CUE N/A
- Revenue Next Year
- CFSB N/A
- CUE $23.84
- P/E Ratio
- CFSB N/A
- CUE N/A
- Revenue Growth
- CFSB N/A
- CUE N/A
- 52 Week Low
- CFSB $6.34
- CUE $0.45
- 52 Week High
- CFSB $13.98
- CUE $1.99
- Technical
- Relative Strength Index (RSI)
- CFSB 64.64
- CUE 53.41
- Support Level
- CFSB $13.86
- CUE $0.76
- Resistance Level
- CFSB $13.93
- CUE $0.84
- Average True Range (ATR)
- CFSB 0.02
- CUE 0.08
- MACD
- CFSB -0.03
- CUE -0.00
- Stochastic Oscillator
- CFSB 46.67
- CUE 61.86
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.